Report

Global Testosterone Replacement Therapy Market Size study & Forecast, by Product (Injectables, Topicals, Others) and Regional Analysis, 2022-2029

  • Publish Date: Oct,2022
  • Report ID: 3-8-1019
  • Page : 200
  • Report Type : PDF (Email)
Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Testosterone Replacement Therapy Market, by Region, 2019-2029 (USD Billion)
1.2.2. Testosterone Replacement Therapy Market, by Product, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Testosterone Replacement Therapy Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Testosterone Replacement Therapy Market Dynamics
3.1. Testosterone Replacement Therapy Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Increasing prevalence of testosterone deficiency
3.1.1.2. Growing Geriatric Population
3.1.2. Market Challenges
3.1.2.1. Strict rules and regulations
3.1.3. Market Opportunities
3.1.3.1. Rising initiatives by the key market players
Chapter 4. Global Testosterone Replacement Therapy Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Investment Adoption Model
4.5. Analyst Recommendation & Conclusion
4.6. Top investment opportunity
4.7. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Testosterone Replacement Therapy Market, by Product
6.1. Market Snapshot
6.2. Global Testosterone Replacement Therapy Market by Product, Performance - Potential Analysis
6.3. Global Testosterone Replacement Therapy Market Estimates & Forecasts by Product, 2019-2029 (USD Billion)
6.4. Testosterone Replacement Therapy Market, Sub Segment Analysis
6.4.1. Injectables
6.4.2. Topicals
6.4.3. Others
Chapter 7. Global Testosterone Replacement Therapy Market, Regional Analysis
7.1. Testosterone Replacement Therapy Market, Regional Market Snapshot
7.2. North America Testosterone Replacement Therapy Market
7.2.1. U.S. Testosterone Replacement Therapy Market
7.2.1.1. Product breakdown estimates & forecasts, 2019-2029
7.2.2. Canada Testosterone Replacement Therapy Market
7.3. Europe Testosterone Replacement Therapy Market Snapshot
7.3.1. U.K. Testosterone Replacement Therapy Market
7.3.2. Germany Testosterone Replacement Therapy Market
7.3.3. France Testosterone Replacement Therapy Market
7.3.4. Spain Testosterone Replacement Therapy Market
7.3.5. Italy Testosterone Replacement Therapy Market
7.3.6. Rest of Europe Testosterone Replacement Therapy Market
7.4. Asia-Pacific Testosterone Replacement Therapy Market Snapshot
7.4.1. China Testosterone Replacement Therapy Market
7.4.2. India Testosterone Replacement Therapy Market
7.4.3. Japan Testosterone Replacement Therapy Market
7.4.4. Australia Testosterone Replacement Therapy Market
7.4.5. South Korea Testosterone Replacement Therapy Market
7.4.6. Rest of Asia Pacific Testosterone Replacement Therapy Market
7.5. Latin America Testosterone Replacement Therapy Market Snapshot
7.5.1. Brazil Testosterone Replacement Therapy Market
7.5.2. Mexico Testosterone Replacement Therapy Market
7.6. Rest of The World Testosterone Replacement Therapy Market
Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. AbbVie Inc
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. Endo Pharmaceuticals Inc
8.2.3. Pfizer, Inc
8.2.4. Eli Lilly and Company
8.2.5. Bayer AG
8.2.6. Teva Pharmaceutical Industries Ltd
8.2.7. Ferring Pharmaceuticals
8.2.8. Acerus Pharmaceuticals Corporation
8.2.9. Mylan N.V
8.2.10. Perrigo Company Plc
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption